Get started
Author

Virginia Pérez‐Grijalba

Observed names: Perez-Grijalba, Virginia, Pérez-Grijalba, V., Pérez-Grijalba, Virginia, V Pérez-Grijalba, V. Pérez-Grijalba, V. Pérez‐Grijalba, Virginia Pérez-Grijalba, Virginia Pérez Grijalba, Virginia Pérez-Grijalba
Observed institutions: Universitat Autònoma de Barcelona, The University of Melbourne, Florey Institute of Neuroscience and Mental Health, Royal Brisbane and Women's Hospital, Instituto de Salud Carlos III, Universitat Internacional de Catalunya, Biomedical Research Networking Center on Neurodegenerative Diseases, Institut d'Investigació Biomédica de Bellvitge, Hôpital Ophtalmique Jules-Gonin, Centro de Investigación Biomédica en Red de Salud Mental, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Fondation Asile des Aveugles, Fundació ACE, Grifols (Spain), Vall d'Hebron Hospital Universitari, Clinica Universidad de Navarra, Center for Biomedical Research of La Rioja, Australian e-Health Research Centre, CSIRO Health and Biosecurity, Instituto Aragonés de Ciencias de la Salud, Servicio Riojano de Salud, University of Lausanne
ORCID: 0000-0002-7062-827X
Observed ORCID: 0000-0002-7062-827X
OpenAlex ID: A5004584329
Total Aβ 42 /Aβ 40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis
2020 · James D. Doecke, Virginia Pérez-Grijalba, et al. · Neurology · 204
PDF
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
2017 · Noelia Fandos, Virginia Pérez‐Grijalba, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 204
PDF
Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study
2019 · V. Pérez-Grijalba, J. Romero, et al. · The Journal of Prevention of Alzheimer s Disease · 151
Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial
2018 · Ana-María Lacosta, María Pascual-Lucas, et al. · Alzheimer s Research & Therapy · 128
PDF
Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease
2013 · Rocio Perez-Gonzalez, Consuelo Pascual, et al. · Neurobiology of Aging · 93
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
2019 · The AB255 Study Group, Virginia Pérez-Grijalba, et al. · Alzheimer s Research & Therapy · 60
PDF
Reliable Measurements of theβ-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD
2012 · Pedro Pesini, Virginia Pérez-Grijalba, et al. · International Journal of Alzheimer s Disease · 59
PDF
Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)
2018 · on behalf of the FACEHBI study, Itziar de Rojas, et al. · Alzheimer s Research & Therapy · 56
PDF
The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline
2018 · Angela Sanabria, Montserrat Alegret, et al. · Scientific Reports · 53
PDF
Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer’s disease
2014 · M. Izco, P. Martínez, et al. · Neuroscience · 46
Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
2013 · Agustín Ruiz, Pedro Pesini, et al. · PLoS ONE · 46
PDF
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results
2017 · Sonia Moreno–Grau, Octavio Rodríguez‐Gómez, et al. · Alzheimer s & Dementia · 41
PDF
Longitudinal evaluation of the natural history of amyloid-β in plasma and brain
2020 · Samantha C Burnham, Noelia Fandos, et al. · Brain Communications · 35
PDF
New insights into genetic variant spectrum and genotype–phenotype correlations of Rubinstein‐Taybi syndrome in 39 CREBBP‐positive patients
2019 · Virginia Pérez‐Grijalba, Alberto García‐Oguiza, et al. · Molecular Genetics & Genomic Medicine · 32
PDF
Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma
2016 · Virginia Pérez-Grijalba, Noelia Fandos, et al. · Journal of Alzheimer s Disease · 27
PDF
Aβ1-17 is a Major Amyloid-β Fragment Isoform in Cerebrospinal Fluid and Blood with Possible Diagnostic Value in Alzheimer's Disease
2014 · Virginia Pérez-Grijalba, Pedro Pesini, et al. · Journal of Alzheimer s Disease · 21
Several Direct and Calculated Biomarkers from the Amyloid-β Pool in Blood are Associated with an Increased Likelihood of Suffering from Mild Cognitive Impairment
2013 · Virginia Pérez-Grijalba, Pedro Pesini, et al. · Journal of Alzheimer s Disease · 20
PDF
Optimized Protocol for Amyloid-β Extraction from the Brain
2013 · María Izco, Pedro Pesini, et al. · Journal of Alzheimer s Disease · 17
PDF
Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort
2020 · Alba Pérez-Cordón, Gemma Monté-Rubio, et al. · Scientific Reports · 14
PDF
Analysis of the albumin‐bilirubin score as an indicator of improved liver function among hepatitis C virus patients with sustained viral response after direct‐acting antiviral therapy
2022 · Ángela Martínez Herreros, Bruno Sangro, et al. · JGH Open · 13
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease
2016 · José Antonio Allué, Leticia Sarasa, et al. · Journal of Alzheimer s Disease · 13
PDF
Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort
2024 · Matteo Tonietto, Oscar Sotolongo-Grau, et al. · Alzheimer s Research & Therapy · 12
PDF
Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort
2024 · Ainhoa García-Sánchez, Oscar Sotolongo-Grau, et al. · Alzheimer s Research & Therapy · 11
PDF
Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohort
2021 · G. Ortega, A. Espinosa, et al. · Alzheimer s Research & Therapy · 11
PDF
Mitochondrial genetic effect on atrial fibrillation: A case-control study
2020 · Elena Roselló-Díez, Leif Hove-Madsen, et al. · Mitochondrion · 11
Works count: 58
Citation count: 1,402
H-index: 17
I10-index: 26
Year
Topic
Type